Definium Therapeutics Inc. Common Shares vs Semtech Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.09 (market cap $4.59B), while Semtech Corporation Common Stock trades at $184.48 (market cap $17.49B). The key difference: Semtech Corporation Common Stock is far larger — about 3.8× Definium Therapeutics Inc. Common Shares's market cap, and Semtech Corporation Common Stock is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Semtech Corporation Common Stock for 0 Days on average.
| DFTX | SMTC | |
|---|---|---|
Market Cap | $4.59B | $17.49B |
Volume | 2,103,937 | 4,235,937 |
Sector | Health | Technology |
52-Week High | $48.45 | $197.20 |
52-Week Low | $10.68 | $62.57 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $17.78B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Semtech develops analog and mixed-signal semiconductors and connectivity products. Its technologies are used in communications, data centers, industrial systems, and IoT devices.
Read more on SMTC →